A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

NCT04536792 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Anemia, Sickle Cell

Interventions

DRUG: AG-946
DRUG: AG-946 Matched Placebo

Sponsor

Agios Pharmaceuticals, Inc.